238
Participants
Start Date
September 30, 2010
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
Ultrasonography
Standardized ultrasonographic assessment of 32 joints, assessed for both grey scale synovitis and power doppler signal, at each visit. Dose escalations based on DAS response in combination with change in US score. All joints with US Power Doppler signal are targets for intra articular injections.
Martina Hansens Hospital AS, Sandvika
Sykehuset Østfold HF, Dept. of Rheumatology, Moss
Vestre Viken HF, Dept. of Rheumatology, Drammen
Sørlandet Sykehus HF, Dept. of Rheumatology, Kristiansand
Revmatologene bendvold/Dovland, Kristiansand
Helse Bergen HF, Haukeland University Hospital, Dept. of Rheumatology, Bergen
Haugesund Sanitetsforening Revmatismesykehus, Haugesund
Helse Sunnmøre HF, Dept. of Rheumatology, Ålesund
St Olavs Hospital HF, Dept. of Rheumatology, Trondheim
Universitetssykehuset Nord-Norge HF, Dept. of Rheumatology, Tromsø
Diakonhjemmet Sykehus AS, Dept. of Rheumatology, Oslo
The Research Council of Norway
OTHER
Smerud Medical Research International AS
OTHER
Oslo University Hospital
OTHER
Innovest
UNKNOWN
Abbott
INDUSTRY
UCB Nordic A/S
INDUSTRY
Pfizer
INDUSTRY
MSD Norway AS
UNKNOWN
Roche Pharma AG
INDUSTRY
The Norwegian Rheumatism Association
OTHER
Espen A. Haavardsholm
OTHER